● Recruiting

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Condition: Dyslipidemia Associated With Type II Diabetes Mellitus · Sponsor: EMS

PhasePhase 3

Planned participants228

Who can joinAll sexes, 18 Years to 85 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of Berlim 25/20 association in the treatment of type 2 diabetes mellitus and dyslipidemia.

This description comes directly from the study's public registry record.

Talk to the study team

Cassiano O Berto, BD · +551938877724 · pesquisa.clinica@ncfarma.com.br

Always discuss trial participation with your own doctor first.

Locations (1)

Allergisa

Campinas, São Paulo, Brazil

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04602754